Atrial fibrillation in CLL patients on ibrutinib

Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL

Cytogenetic and proteomic prognostic markers of CLL

Expert panel discussion: The best of iwCLL 2015

Primary results from the MABLE phase IIIb study

Results of subgroup analysis of the HELIOS trial

Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors

History of the B-cell in its 50th anniversary year

Human B-cell receptor structure and function in CLL

Translational research and the future of CLL treatment

The p-medicine project and ECRIN